ClavystBio
Venture studioSingapore · Seed–Series A · 33 people tracked
Investment thesis
ClavystBio operates as both a life sciences investor and a venture builder, focusing on creating and scaling global biotech companies. It fosters company creation and growth via active incubation and investment, while forging public and private partnerships and accelerating talent development to drive commercialization within its innovation community.
Source: firm website, verified Aug 3, 2026.
Team · 33 people
from the firm's website & public directoriesWhat they invest in
from 5 of 21 portfolio companiesBiotech ×5Healthtech ×2AI & Machine Learning ×1Deep Tech ×1Medical Devices ×1PropTech ×1
HQs:United States×2Netherlands×1Singapore×1
Investments · 21 tracked
founders shown can be your intro pathEarly-stage biotech company developing autophagy-based targeted protein degradation therapeutics for cancer and genetic diseases.
Seattle and Singapore-based biotech developing next-generation multi-payload antibody-drug conjugates for cancer treatment.
Ocular immunology-focused biotech developing cell and gene therapies for age-related macular degeneration and other chronic blinding diseases.
Biotech company developing booster vaccines and therapeutics against SARS-2 beta coronavirus variants.
Specialist biotech investor focusing on precision therapeutics for oncology and genetic disease from newly founded through early clinical-stage.
Singapore and US-based precision medicine biotech using machine learning and experimental biology to develop cancer and disease therapies.
Global ophthalmology company using a hub-and-spoke model to develop a diversified pipeline of eye care therapies and devices.
Hummingbird Bioscience develops antibody-based therapeutics, including antibody-drug conjugates (ADCs), using proprietary linker-payload and biologics discovery platforms.
BiotechHealthtech
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses at the nasal mucosa to prevent initial infection and transmission.
BiotechHealthtechMedical DevicesLeiden, NL
Koenraad Wiedhaup(Founder and Chief Executive Officer)inRonald Brus(Founder and Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)in
Global venture capital firm investing in early-stage and opportunistic late-stage therapeutic and life science companies.
Singapore-based immune engineering company developing novel cellular therapies for T-cell malignancies and autoimmune diseases.
Paratus Sciences develops first-in-class medicines for cardiometabolic and immune & inflammatory diseases by leveraging evolutionary biology and AI to identify novel drug targets.
AI & Machine LearningBiotechDeep TechUnited States, US
Global venture capital firm investing in disruptive healthcare and technology companies through active partnership and mentorship.
Generative AI-powered digital health platform providing personalized interventions for stress, anxiety, insomnia, and mental health challenges.
Hydrogel product to prevent intrauterine adhesions after uterine surgery
BiotechBedford, US
AMARPREET SAWHNEY(Executive Officer, Director, Promoter)NICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)
BoardTARA BUTLER(Executive Officer, Director, Promoter)
Venture capital firm with offices in Japan and the United States focusing on company creation based on innovative science and early-stage products.
AI/ML health tech company building clinically-validated artificial intelligence for measuring and tracking disease progression across healthcare settings.
Portfolio news
latest coverage across their companiesLeyden Labs · firstwordpharma.com · Jun 29, 2026
Frequently asked questions
- What stage does ClavystBio invest at?
- ClavystBio invests at the Seed, Series A stages.
- What sectors does ClavystBio focus on?
- ClavystBio focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is ClavystBio located?
- ClavystBio is headquartered in Singapore, SG.
Images
Similar investors
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
































